These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 44211)

  • 21. [Complications observed during use of lithium salt-neuroleptic combinations; comparative study of clinical evolution, EEG and pharmacokinetics].
    Granier F; Girard M; Loustalan JM; Thomas J; Escande M
    Ann Med Psychol (Paris); 1983; 141(8):891-908. PubMed ID: 6141759
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported developmental changes in the frequency and characteristics of somnambulistic and sleep terror episodes in chronic sleepwalkers.
    Kalantari N; McDuff P; Pilon M; Desautels A; Montplaisir JY; Zadra A
    Sleep Med; 2022 Jan; 89():147-155. PubMed ID: 34990921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy.
    Dinan TG; Kohen D
    Br J Psychiatry; 1989 Jul; 155():55-7. PubMed ID: 2575003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium and neuroleptic drug combination: lack of an effect on blood glucose.
    King DJ
    Br J Clin Pharmacol; 1978 Nov; 6(5):436-7. PubMed ID: 31896
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurotoxicity with combined use of lithium and thioridazine.
    Spring GK
    J Clin Psychiatry; 1979 Mar; 40(3):135-8. PubMed ID: 106047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incompatibility of lithium therapy with neuroleptics. a case report (author's transl)].
    Pühringer W; Kocher R; Gastpar M
    Nervenarzt; 1979 Feb; 50(2):124-7. PubMed ID: 34111
    [No Abstract]   [Full Text] [Related]  

  • 30. Medication-induced somnambulism in a patient with schizoaffective disorder.
    Glassman JN; Darko D; Gillin JC
    J Clin Psychiatry; 1986 Oct; 47(10):523-4. PubMed ID: 3093469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic.
    Sernyak MJ; Griffin RA; Johnson RM; Pearsall HR; Wexler BE; Woods SW
    Am J Psychiatry; 1994 Jan; 151(1):133-5. PubMed ID: 7903511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The question of lithium/neuroleptic toxicity.
    Jeffries J; Remington G; Wilkins J
    Can J Psychiatry; 1984 Nov; 29(7):601-4. PubMed ID: 6150756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Priapism associated with thiothixene, chlorpromazine, and thioridazine.
    Balon R; Berchou R; Han H
    J Clin Psychiatry; 1987 May; 48(5):216. PubMed ID: 3571177
    [No Abstract]   [Full Text] [Related]  

  • 34. Dissimilar dosing with high-potency and low-potency neuroleptics.
    Baldessarini RJ; Katz B; Cotton P
    Am J Psychiatry; 1984 Jun; 141(6):748-52. PubMed ID: 6145357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic plasma levels.
    Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
    Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sudden cessation of psychotropic drugs].
    Avrutskii GIa; Gurovich IIa; Prokhorova IS; Tirkel'taub IuA; Romanov IuD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):923-30. PubMed ID: 4156142
    [No Abstract]   [Full Text] [Related]  

  • 37. [Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination?].
    Habib M; Khalil R; le Pensec-Bertrand D; Ali-Cherif A; Bongrand MC; Crevat A
    Rev Neurol (Paris); 1986; 142(1):61-4. PubMed ID: 2871617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
    Remington GJ; Voineskos G; Pollock B; Reed K; Coulter K
    Am J Psychiatry; 1990 Sep; 147(9):1231-3. PubMed ID: 1974747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotic patients who become worse on neuroleptics.
    Bowers MB; Swigar ME
    J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The strategy and value of neuroleptic drug monitoring.
    Curry SH
    J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.